Reingold SC - Search Results

1

The role of magnetic resonance techniques in understanding and managing multiple sclerosis.

Miller DH, Grossman RI, Reingold SC, McFarland HF. Miller DH, et al. Among authors: reingold sc. Brain. 1998 Jan;121 ( Pt 1):3-24. doi: 10.1093/brain/121.1.3. Brain. 1998. PMID: 9549485 Review.

2

Revised estimate of the prevalence of multiple sclerosis in the United States.

Anderson DW, Ellenberg JH, Leventhal CM, Reingold SC, Rodriguez M, Silberberg DH. Anderson DW, et al. Among authors: reingold sc. Ann Neurol. 1992 Mar;31(3):333-6. doi: 10.1002/ana.410310317. Ann Neurol. 1992. PMID: 1637140

3

Human T-lymphotrophic virus type I and multiple sclerosis.

Antel J, Bangham C, Reingold SC. Antel J, et al. Among authors: reingold sc. Ann Neurol. 1990 Jun;27(6):689-90. doi: 10.1002/ana.410270619. Ann Neurol. 1990. PMID: 2360808 No abstract available.

4

Workshop on Neurobehavioral Disorders in Multiple Sclerosis. Diagnosis, underlying disease, natural history, and therapeutic intervention, Bergamo, Italy, June 25-27, 1992.

Rao SM, Reingold SC, Ron MA, Lyon-Caen O, Comi G. Rao SM, et al. Among authors: reingold sc. Arch Neurol. 1993 Jun;50(6):658-62. doi: 10.1001/archneur.1993.00540060088026. Arch Neurol. 1993. PMID: 8099276 No abstract available.

5

Megadose corticosteroids in multiple sclerosis.

Kupersmith MJ, Kaufman D, Paty DW, Ebers G, McFarland H, Johnson K, Reingold S, Whitaker J. Kupersmith MJ, et al. Neurology. 1994 Jan;44(1):1-4. doi: 10.1212/wnl.44.1.1. Neurology. 1994. PMID: 8290041 No abstract available.

6

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, Lublin FD, Paty DW, Reingold SC, Simon J. Miller DH, et al. Among authors: reingold sc. Ann Neurol. 1996 Jan;39(1):6-16. doi: 10.1002/ana.410390104. Ann Neurol. 1996. PMID: 8572668

7

Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Lublin FD, Reingold SC. Lublin FD, et al. Among authors: reingold sc. Neurology. 1996 Apr;46(4):907-11. doi: 10.1212/wnl.46.4.907. Neurology. 1996. PMID: 8780061

8

Clinical outcomes assessment in multiple sclerosis.

Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E. Rudick R, et al. Ann Neurol. 1996 Sep;40(3):469-79. doi: 10.1002/ana.410400321. Ann Neurol. 1996. PMID: 8797541 Review.

9

Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: relations between study investigators, advisors, and sponsors. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Lublin FD, Reingold SC. Lublin FD, et al. Among authors: reingold sc. Neurology. 1997 Mar;48(3):572-4. doi: 10.1212/wnl.48.3.572. Neurology. 1997. PMID: 9065528 No abstract available.

10

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.

Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E. Rudick R, et al. Ann Neurol. 1997 Sep;42(3):379-82. doi: 10.1002/ana.410420318. Ann Neurol. 1997. PMID: 9307263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results